本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Entasis Therapeutics Holdings Inc.

2.19
+0.0000
成交量:- -
成交额:14.28万
市值:1.05亿
市盈率:-1.95
高:2.19
开:2.19
低:2.19
收:2.19
数据加载中...
2022/07/11

交易所摘牌声明

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2022/07/11

重要事件披露

8-K - Current report
2022/07/11

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/07/11

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/07/11

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/07/11

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/07/11

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/07/11

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/07/11

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/07/08

私有化交易

SC 13E3/A [Amend] - Going private transaction by certain issuers
2022/07/08

私有化交易

SC 13E3/A [Amend] - Going private transaction by certain issuers
2022/06/17

SEC问询函

CORRESP [Cover] - Correspondence
2022/06/17

私有化交易

SC 13E3/A [Amend] - Going private transaction by certain issuers
2022/06/17

私有化交易

SC 13E3/A [Amend] - Going private transaction by certain issuers
2022/06/07

私有化交易

SC 13E3 - Going private transaction by certain issuers
2022/06/07

私有化交易

SC 13E3 - Going private transaction by certain issuers
2022/05/24

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/05/23

重要事件披露

8-K - Current report
2022/05/02

[修订]年度报告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/04/27

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]